Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network

被引:2
|
作者
McGill, Janet B. [1 ]
Wu, Mengdi [2 ]
Pop-Busui, Rodica [3 ]
Mizokami-Stout, Kara [3 ]
Tamborlane, William, V [4 ]
Aleppo, Grazia [5 ]
Gubitosi-Klug, Rose A. [6 ]
Haller, Michael J. [7 ]
Willi, Steven M. [8 ,11 ]
Foster, Nicole C. [2 ]
Zimmerman, Chelsea [7 ]
Libman, Ingrid [9 ]
Polsky, Sarit [10 ]
Rickels, Michael R. [11 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Jaeb Ctr Hlth Res, 15310 Amberly Dr,Suite 350, Tampa, FL 33647 USA
[3] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Northwestern Univ, Chicago, IL 60611 USA
[6] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[7] Univ Florida, Gainesville, FL USA
[8] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[9] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA
[10] Barbara Davis Ctr Diabet, Aurora, CO USA
[11] Univ Penn, Rodebaugh Diabet Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
Type; 1; diabetes; Diabetic kidney disease; T1D exchange; Diabetes management; Glycemic management; CONVERTING ENZYME-INHIBITION; GLOMERULAR-FILTRATION-RATE; INSULIN INJECTION THERAPY; GLYCEMIC CONTROL; PITTSBURGH EPIDEMIOLOGY; SOCIOECONOMIC-STATUS; COMPLICATIONS TRIAL; BLOOD-PRESSURE; FOLLOW-UP; ALBUMINURIA;
D O I
10.1016/j.jdiacomp.2019.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Diabetic kidney disease (DKD) is a major complication of type 1 diabetes (T1D). To better understand the development of DKD in modern clinical practice, we evaluated risk factors in participants from the T1D Exchange Registry who completed 5-years of longitudinal follow-up. Methods: Participants had T1D duration >= 1 year, age >= 10 years, eGFR >= 60 ml/min and no albuminuria at enrollment, and at least two serum creatinine and urine albumin measurements recorded during follow-up. Adverse kidney outcomes were defined as eGFR << 60 ml/min and/or albuminuria (ALB) defined by as two consecutive albumin/creatinine ratios or two out of the past three measurements >> 30 mu g/mg at any follow-up data collection. Associations of baseline characteristics with adverse kidney outcomes were assessed. Results: Among 3940 participants (mean age 41 +/- 15 yrs, T1D duration 21 +/- 13 yrs), 653 (16.6%) experienced an adverse kidney outcome: 268 (6.8%) experienced incident ALB only, 322 (8.2%) had eGFR decline to << 60 ml/min without ALB, and 63 (1.6%) experienced eGFR << 60 ml/min with ALB. In a multivariable analysis, higher HbA1c, higher SBP, lower DBP, older age and lower education level were associated with the development of adverse kidney outcomes (all p values <= 0.03). Conclusions: Improving modifiable risk factors, including glucose and blood pressure control, remain important to reduce the risk of DKD in T1D. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes
    Popovic, Djordje S.
    Patoulias, Dimitrios
    Gnudi, Luigi
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 151
  • [42] Improvement in A1c Levels in Early Adulthood in the T1D Exchange: Impact of Racial, Socioeconomic, and Clinical Factors
    Toschi, Elena
    Bailey, Ryan J.
    Miller, Kellee M.
    Calhoun, Peter M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05) : 1294 - 1302
  • [43] Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry
    Nambam, Bimota
    DuBose, Stephanie N.
    Nathan, Brandon M.
    Beck, Roy W.
    Maahs, David M.
    Wadwa, R. Paul
    Tamborlane, William V.
    Foster, Nicole C.
    Miller, Kellee M.
    Haller, Michael J.
    PEDIATRIC DIABETES, 2016, 17 (01) : 15 - 20
  • [44] T1D exchange quality improvement collaborative: Accelerating change through benchmarking and improvement science for people with type 1 diabetes COMMENT
    Prahalad, Priya
    Rioles, Nicole
    Noor, Nudrat
    Rapaport, Robert
    Weinstock, Ruth S.
    Ebekozien, Osagie
    JOURNAL OF DIABETES, 2022, 14 (01) : 83 - 87
  • [45] Type 1 diabetes management responsibilities between adolescents with T1D and their parents: An integrative review
    Farthing, Pamela
    Bally, Jill
    Rennie, Donna C.
    Leurer, Marie Dietrich
    Holtslander, Lorraine
    Nour, Munier A.
    JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING, 2022, 27 (04)
  • [46] HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry Findings
    Miller, Kellee M.
    Beck, Roy W.
    Foster, Nicole C.
    Maahs, David M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (09) : 645 - 650
  • [47] Feasibility of screening for T1D and celiac disease in a pediatric clinic setting
    Gesualdo, Patricia D.
    Bautista, Kimberly A.
    Waugh, Kathleen C.
    Yu, Liping
    Norris, Jill M.
    Rewers, Marian J.
    Baxter, Judith
    PEDIATRIC DIABETES, 2016, 17 (06) : 441 - 448
  • [48] Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries
    Shah, Viral N.
    Grimsmann, Julia M.
    Foster, Nicole C.
    Dost, Axel
    Miller, Kellee M.
    Pavel, Marianne
    Weinstock, Ruth S.
    Karges, Wolfram
    Maahs, David M.
    Holl, Reinhard W.
    DIABETES OBESITY & METABOLISM, 2020, 22 (09) : 1577 - 1585
  • [49] Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries
    Weinstock, Ruth S.
    Schutz-Fuhrmann, Ingrid
    Connor, Crystal G.
    Hermann, Julia M.
    Maahs, David M.
    Schuett, Morten
    Agarwal, Shivani
    Hofer, Sabine E.
    Beck, Roy W.
    Holl, Reinhard W.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 122 : 28 - 37
  • [50] Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes
    Adeshara, Krishna
    Gordin, Daniel
    Antikainen, Anni A.
    Harjutsalo, Valma
    Sandholm, Niina
    Lehto, Markku J.
    Groop, Per-Henrik
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)